pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
globenewswire health·Aug 5·1 min read
save

Danske Bank reports ongoing share buy-back sales by APMH Invest under regulatory disclosure

Aug 5, 2026·read at globenewswire health ↗RegulatoryNeutral

On 5 August 2026 Danske Bank A/S filed a notification under the EU Market Abuse Regulation describing transactions by persons required to report to the Danish FSA and Nasdaq Copenhagen.

The bank disclosed that APMH Invest A/S is continuously selling shares on a pro rata basis as part of Danske Bank's share buy-back program.

The filing includes templates for further public disclosure and provides a media contact for additional information.

source

This writeup was produced by pharmadog from original reporting by globenewswire health.

Original headline: “Danske Bank A/S, transactions by persons discharging managerial responsibilities”

read at globenewswire health ↗
87 words · retrieved Aug 5
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • Aug 10Aspo Oyj - Johdon liiketoimetglobenewswire health
  • Aug 10Aspo Plc - Managers' Transactionsglobenewswire health
  • Aug 7Ledende medarbejder transaktionglobenewswire health
  • Aug 7Ledende medarbejders køb af aktierglobenewswire health
  • Aug 6Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officerglobenewswire health